Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year

  1. Moncada, E.
  2. Subirá, M.L.
  3. Oleaga, A.
  4. Goñi, F.
  5. Sánchez-Ibarrola, A.
  6. Monreal, M.
  7. Sevilla, M.
  8. Goñi, M.J.
  9. Yoldi, A.
  10. Terán, D.
  11. Llorente, I.
Aldizkaria:
Journal of Autoimmunity

ISSN: 1095-9157 0896-8411

Argitalpen urtea: 1990

Alea: 3

Zenbakia: 5

Orrialdeak: 625-638

Mota: Artikulua

DOI: 10.1016/S0896-8411(05)80030-7 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak